Related Experiment Video
Updated: Jul 11, 2026
08:17
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis
Simone C Tauber1, Roland Nau, Joachim Gerber
1Department of Neurology, Georg-August-University, Göttingen, Germany.
Archives of Physiology and Biochemistry
|October 9, 2007
Summary
Bacterial and viral infections may trigger multiple sclerosis (MS) and related conditions. Early antibiotic treatment for bacterial infections in MS patients is recommended to prevent disease worsening and relapses.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Multiple sclerosis (MS) is an inflammatory central nervous system (CNS) demyelinating disease.
- Viral and bacterial infections are implicated in the pathogenesis of MS.
- Experimental autoimmune encephalomyelitis (EAE) serves as a model for MS research.
Purpose of the Study:
- To review the influence of viral and bacterial infections on MS and EAE.
- To focus on the role of bacterial infections in MS pathogenesis.
- To examine the therapeutic implications, including antibiotic treatment effects on EAE.
Main Methods:
- Literature review of studies on infections and MS/EAE.
- Analysis of experimental data from EAE models.
- Evaluation of clinical evidence from MS patients.
Main Results:
- Systemic infections are identified as a risk factor for initiating autoimmune processes.
- Infections can induce acute events in MS.
- Antibiotic treatment can impact the course of EAE.
Conclusions:
- Evidence supports a link between systemic infections and autoimmune diseases like MS.
- Early intervention for bacterial infections in MS patients is crucial.
- Prompt treatment may prevent disease exacerbation and reduce relapse rates.
More Related Videos
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...